Table 1.

Baseline characteristics of crossover patients from study TIVO-1 to study 902 (N = 161).

Baseline characteristics	Evaluable population (N = 161)
Gender
Female	46 (20)
Male	115 (71)
Age
Median	59.0
Range	23–85
Age group
<65 years	127 (79)
≥65 years	34 (21)
Race
White	156 (97)
Asian	5 (3)
ECOG PS
0	92 (57)
1	69 (43)
Geographic region
Central/Eastern Europe	143 (89)
North America/Western Europe	10 (6)
Rest of world	8 (5)

ECOG PS, Eastern Cooperative Oncology Group performance status. Data are n (%), unless otherwise specified.